Probi AB Stock

Equities

PROB

SE0001280355

Pharmaceuticals

Market Closed - Nasdaq Stockholm 11:15:07 2024-05-28 am EDT 5-day change 1st Jan Change
231 SEK +11.06% Intraday chart for Probi AB +11.06% +13.79%
Sales 2024 * 654M 61.91M Sales 2025 * 699M 66.17M Capitalization 2.37B 224M
Net income 2024 * 15M 1.42M Net income 2025 * 32M 3.03M EV / Sales 2024 * 3.16 x
Net cash position 2024 * 303M 28.68M Net cash position 2025 * 345M 32.66M EV / Sales 2025 * 2.9 x
P/E ratio 2024 *
155 x
P/E ratio 2025 *
74.6 x
Employees -
Yield 2024 *
0.72%
Yield 2025 *
0.93%
Free-Float 28.19%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.44%
1 week+2.93%
Current month+3.94%
1 month+3.94%
3 months+5.50%
6 months+3.94%
Current year+3.94%
More quotes
1 week
202.00
Extreme 202
217.00
1 month
199.00
Extreme 199
217.00
Current year
181.00
Extreme 181
239.00
1 year
171.50
Extreme 171.5
239.00
3 years
165.00
Extreme 165
660.00
5 years
139.20
Extreme 139.2
660.00
10 years
42.50
Extreme 42.5
660.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 52 22-03-31
Director of Finance/CFO 58 Oct. 31
Director/Board Member 44 13-12-31
Members of the board TitleAgeSince
Director/Board Member 53 20-05-12
Chairman 60 15-03-31
Director/Board Member 62 17-05-03
More insiders
Date Price Change Volume
24-05-28 231 +11.06% 772
24-05-27 208 -1.89% 36
24-05-24 212 +0.95% 374
24-05-23 210 +1.94% 205
24-05-22 206 +0.49% 112

Delayed Quote Nasdaq Stockholm, May 28, 2024 at 03:39 am EDT

More quotes
Probi AB is a Sweden-based company engaged in the probiotics research and development. The Company’s activities are divided into two business areas: Functional Foods, which focuses on the probiotics application in food in partnership with food companies; and Consumer Healthcares, which develops, commercializes and sells Probi probiotics in collaboration with a range of entities, such as pharmaceutical companies and firms related to the production of probiotics and self-care goods. Its brands portfolio comprises two trademarks: Probi Digestis and Probi Defendum. The Company's partners include Danone, Skanemejerier, NextFoods, Sanum Polska, Heinz, Kraft Foods, and Institut Rosell, among others. The Company is a parent of Probi Food AB and Probi Feed AB.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings